• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Idenix Pharmaceuticals Inc

+ Add to Watchlist


24.4400 USD 0.0200 0.08%

As of 17:20:00 ET on 08/01/2014.

Snapshot for Idenix Pharmaceuticals Inc (IDIX)

Open: 24.4500 Day's Range: 24.4000 - 24.4700 Volume: 1,403,785
Previous Close: 24.4200 52wk Range: 2.9301 - 24.4700 1-Yr Rtn: +517.17%

Stock Chart for IDIX

No chart data available.
  • IDIX:US 24.4400
  • 1D
  • 1M
  • 1Y
Interactive IDIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IDIX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.1140
Est. EPS (USD) (12/2014) -0.8700
Est. PEG Ratio -
Market Cap (M USD) 3,702.75
Shares Outstanding (M) 151.50
30 Day Average Volume 1,879,860
Price/Book (mrq) 24.2051
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IDIX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IDIX

Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).

Ronald C Renaud Jr "Ron"President/CEODouglas MayersExec VP/Chief Medical Officer
Jacques DumasExec VP/Chief Scientific OfcrDaniella BeckmanSenior VP/CFO/Treasurer
More Company Profile & Key Executives for IDIX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil